Results 131 to 140 of about 5,220,417 (172)

PIK3CA inhibitor treatment for metastatic scrotal extramammary Paget's disease: a case report and literature review. [PDF]

AME Case Rep
Huang Y, Dong S, Ren J, Li J, Wu C, Chen H, Liu Y, Yuan J, Huang J, Xiao L.   +9 more
europepmc   +1 more source

Carelizumab and rivoceranib for advanced extramammary Paget's disease: an investigator-initiated multicenter, single-arm, phase II trial. [PDF]

Oncologist
Zhang S, Ju M, Wang Q, Zhu D, Liu Z, Ye X, Li W.   +6 more
europepmc   +1 more source

Efficacy and safety of trastuzumab emtansine in patients with advanced human epidermal growth factor receptor 2-positive extramammary Paget's disease: an investigator-initiated, open-label, single-arm, multicentre, prospective, phase II clinical trial (TEMENOS-2). [PDF]

ESMO Open
Arakawa S, Hirai I, Nakamura Y, Uchi H, Ohe S, Isei T, Takenouchi T, Mori S, Takai T, Yoshikawa S, Fujimura T, Yamamoto Y, Ozaki T, Takemura R, Funakoshi T.   +14 more
europepmc   +1 more source

Extramammary Paget’s Disease in Prostate

Urology Journal, 2009
Amit Kumar Yadav, Richa Gupta, Usha Rani Singh   +2 more
doaj  

Antibody-drug conjugate (disitamab vedotin) therapy targeting HER2-low or higher advanced extramammary Paget's disease. [PDF]

Oncologist
Zhang S, Zhou J, Zhao X, Gan H, Peng W, Li W, Sun M, Hu J, Yan W.   +8 more
europepmc   +1 more source

Assessing mortality risk and causes in extramammary Paget's disease: insights from a population-based study. [PDF]

Transl Cancer Res
Qiu X, Yu DD, Dong H, Liu X.
europepmc   +1 more source

Extramammary Paget's disease of the scrotum

Asian Journal of Surgery
Xinlong Chen, Degui Chang, Chenjian Tang
doaj   +1 more source

Primary Extramammary Paget's Disease Following Previously Treated Secondary Extramammary Paget's Disease Over the Scrotum: A Rare Case Successfully Treated With Mohs Micrographic Surgery. [PDF]

Cureus
Verma KK, Ahmad N, Friedmann DP, Ransdell BL, Tarbox M.   +4 more
europepmc   +1 more source

Clinical Outcomes and Prognostic Factors for Extramammary Paget's Disease Treated with Radiation Therapy: A Multi-Institutional Observational Study. [PDF]

Cancers (Basel)
Niwa M, Tomita N, Ishiyama H, Kaneko H, Oshima Y, Takano H, Matsuo M, Kuno M, Miyakawa A, Otsuka S, Takaoka T, Okazaki D, Torii A, Kita N, Takano S, Nakamura M, Kato H, Morita A, Hiwatashi A.   +18 more
europepmc   +1 more source

Immunotherapy may be more appropriate for ERBB2 low-expressing extramammary paget's disease patients: a prognosis analysis and exploration of targeted therapy and immunotherapy of extramammary paget's disease patients. [PDF]

Cancer Immunol Immunother
Yang J, Chen Y, Zhang X, Tong Z, Weng S, Zhu N, Yuan Y.   +6 more
europepmc   +1 more source